| No Metabolic Syndrome | Metabolic Syndrome | ||||
---|---|---|---|---|---|---|
Variable | Controls | HIV-1 untreated | HIV-1 cART | Controls | HIV-1 untreated | HIV-1 cART |
(n = 39) | (n = 32) | (n = 42) | (n = 10) | (n = 16) | (n = 12) | |
Central systolic BP | 113 ± 12 | 116 ± 10 | 114 ± 10 | 126 ± 7c | 120 ± 13 | 110 ± 11b |
Peripheral systolic BP | 123 ± 13a | 127 ± 11a | 124 ± 11a | 135 ± 7ac | 129 ± 11a | 120 ± 13a |
Central diastolic BP | 75 ± 7 | 78 ± 6 | 78 ± 8 | 81 ± 3c | 78 ± 6 | 74 ± 7b |
Peripheral diastolic BP | 74 ± 7a | 77 ± 6a | 76 ± 8a | 79 ± 3ac | 72 ± 7a | 72 ± 7ab |
Central MAP | 87 ± 8 | 91 ± 7 | 90 ± 9 | 96 ± 3c | 92 ± 7 | 86 ± 8b |
Peripheral MAP | 90 ± 8a | 93 ± 7a | 92 ± 8a | 98 ± 2ac | 94 ± 7a | 87 ± 8bc |
Central PP | 38 ± 9 | 38 ± 8 | 36 ± 7 | 45 ± 8c | 41 ± 9 | 36 ± 8 |
Peripheral PP | 49 ± 10a | 50 ± 10a | 47 ± 7a | 56 ± 9a | 52 ± 9a | 45 ± 8ab |
PP amplification (ratio) | 1.33 ± 0.17 | 1.33 ± 0.14 | 1.32 ± 0.13 | 1.24 ± 0.12 | 1.29 ± 0.12 | 1.25 ± 0.19 |
Heart rate (beats/min) | 67 ± 11 | 76 ± 10b | 74 ± 11b | 66 ± 7 | 74 ± 6 | 78 ± 13b |